• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在ABO血型不相合的骨髓移植前,采用血浆置换和血浆改性去除抗红细胞抗体。

Plasma exchange and plasma modification for the removal of anti-red cell antibodies prior to ABO-incompatible marrow transplant.

作者信息

Bensinger W I, Buckner C D, Clift R A, Thomas E D

出版信息

J Clin Apher. 1987;3(3):174-7. doi: 10.1002/jca.2920030310.

DOI:10.1002/jca.2920030310
PMID:3549707
Abstract

Plasma exchange (PE) is performed only rarely to remove a specific, well defined antibody. ABO incompatibility in marrow transplantation has allowed us a unique opportunity to compare the effectiveness of three apheresis procedures for removing anti-red cell antibodies. We performed 140 marrow transplants in which a major ABO incompatibility between donor and recipient existed. To avoid a hemolytic transfusion reaction at the time of marrow infusion PE, plasma immunoadsorption (PIA) or whole-blood immunoadsorption (WBIA) was performed a total of 243 times. PE removed a mean of 87% of intravascular IgM and 86% of intravascular IgG directed against red cell antigens. PIA removed 75% and 73% of IgM and IgG, respectively (P less than .001 when compared to PE). Results for WBIA were 66% and 65%, respectively. Thus, PIA and WBIA were less efficient at removing antibody than PE. Furthermore, there were a few specific instances in which PIA or WBIA removed little or no antibody owing to differences in antibody specificity. PIA and WBIA resulted in less platelet consumption than PE. Although somewhat less effective that PE, PIA and WBIA have other advantages that can make them more desirable.

摘要

仅在极少数情况下进行血浆置换(PE)以去除特定的、明确界定的抗体。骨髓移植中的ABO血型不合为我们提供了一个独特的机会,来比较三种血液分离程序去除抗红细胞抗体的效果。我们进行了140例骨髓移植,供体和受体之间存在主要的ABO血型不合。为避免在输注骨髓时发生溶血性输血反应,共进行了243次PE、血浆免疫吸附(PIA)或全血免疫吸附(WBIA)。PE平均去除了87%的血管内针对红细胞抗原的IgM和86%的血管内IgG。PIA分别去除了75%和73%的IgM和IgG(与PE相比,P<0.001)。WBIA的结果分别为66%和65%。因此,PIA和WBIA在去除抗体方面不如PE有效。此外,由于抗体特异性的差异,在一些特定情况下,PIA或WBIA去除的抗体很少或没有。PIA和WBIA导致的血小板消耗比PE少。尽管PIA和WBIA的效果略逊于PE,但它们具有其他优势,可能使其更具可取性。

相似文献

1
Plasma exchange and plasma modification for the removal of anti-red cell antibodies prior to ABO-incompatible marrow transplant.在ABO血型不相合的骨髓移植前,采用血浆置换和血浆改性去除抗红细胞抗体。
J Clin Apher. 1987;3(3):174-7. doi: 10.1002/jca.2920030310.
2
Plasma exchange and immunoadsorption for removal of antibodies prior to ABO incompatible bone marrow transplant.
Artif Organs. 1981 Aug;5(3):254-8. doi: 10.1111/j.1525-1594.1981.tb03998.x.
3
ABO-incompatible marrow transplants.ABO血型不相容的骨髓移植。
Transplantation. 1982 Apr;33(4):427-9. doi: 10.1097/00007890-198204000-00017.
4
Comparing the efficacy of three techniques to reduce isoagglutinin titers in AB0 incompatible kidney transplant recipients.比较三种降低AB0血型不相容肾移植受者同种凝集素效价技术的疗效。
Atheroscler Suppl. 2017 Nov;30:253-256. doi: 10.1016/j.atherosclerosissup.2017.05.017. Epub 2017 Jun 1.
5
Our first experiences in applying an original method for removal of ABO-isoagglutinins in ABO-incompatible kidney recipients.我们在应用一种原创方法去除ABO血型不相容肾移植受者体内ABO同种凝集素方面的首次经验。
Vojnosanit Pregl. 2009 Feb;66(2):117-22. doi: 10.2298/vsp0902117i.
6
Hemotherapy in patients undergoing blood group incompatible bone marrow transplantation.血型不相合骨髓移植患者的血液疗法
Transfusion. 1983 Jul-Aug;23(4):277-85. doi: 10.1046/j.1537-2995.1983.23483276858.x.
7
Plasma exchange for removal of anti-A and anti-B group antibodies in AB0 major-incompatible bone marrow transplantation.
Folia Haematol Int Mag Klin Morphol Blutforsch. 1989;116(3-4):463-7.
8
Immunoadsorption for removal of anti-A and anti-B blood group antibodies in ABO-incompatible bone marrow transplantation.
Blut. 1986 Nov;53(5):379-90. doi: 10.1007/BF00321100.
9
Transplantation of major ABO-incompatible bone marrow depleted of red cells by hydroxyethyl starch.通过羟乙基淀粉去除红细胞的主要ABO血型不相容骨髓移植。
Vox Sang. 1985;48(2):89-104. doi: 10.1111/j.1423-0410.1985.tb00152.x.
10
ABO-incompatible bone-marrow transplantation: removal of red blood cells from donor marrow avoiding recipient antibody depletion.ABO血型不相容的骨髓移植:从供体骨髓中去除红细胞以避免受体抗体耗竭。
Lancet. 1982 Nov 13;2(8307):1061-4. doi: 10.1016/s0140-6736(82)90003-4.

引用本文的文献

1
Haemolysis, pure red cell aplasia and red cell antibody formation associated with major and bidirectional ABO incompatible haematopoietic stem cell transplantation.与主要和双向 ABO 不相容造血干细胞移植相关的溶血、纯红细胞再生障碍和红细胞抗体形成。
Blood Transfus. 2018 Jul;16(4):397-404. doi: 10.2450/2017.0322-16. Epub 2017 Apr 19.
2
Bone marrow transplantation. Part I--Allogeneic.骨髓移植。第一部分——同种异体移植。
West J Med. 1989 Dec;151(6):638-43.